Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations

Main|Search|PHGKB



From National Institutes of Health Web Sites

---

• Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations
  AM Issa et al, Genetics in Medicine, July 10, 2018
• Bringing Precision to Screening for Cancer 
• Cancer Control P.L.A.N.E.T. portal 
  Cancer Control P.L.A.N.E.T. portal provides access to data and resources that can help planners, program staff, and researchers design, implement and evaluate evidence-based cancer control programs.
• Gene Fusion May Drive Rare Childhood Brain Tumor 
• Genetics of Skin Cancer (PDQ®)–Health Professional Version 
• Head and Neck Cancer: Building the Evidence Base for Precision Oncology
  Posted on February 10, 2015 by Dr. Francis Collins
• Heart Disease in Women 
  From NHBLI health topic site
• NCI-MATCH trial will link targeted cancer drugs to gene abnormalities 
• NCI-MATCH: A Status Report and Future Directions 
• Stomach (Gastric) Cancer Prevention (PDQ®)–Health Professional Version 
• Targeted Photoimmunotherapy Approach for Cancer Moves Forward 
• Thrombotic Thrombocytopenic Purpura 
  From NHBLI health topic site